Introduction

hibernicor_mainimg2.jpg
Heart transplant recipient, James Jahoda, enjoys a rest following 2 weeks of scuba diving in Aruba. Since his surgery, he and his wife have climbed Machu Picchu, hiked in the Swiss alps, biked from Amsterdam to Brussels, and snorkeled in the Turks and Caicos.

Hibernicor, LLC is a medical technology company committed to providing the benchmark of quality and leads the industry in FDA and CE compliance. Hibernicor is dedicated to improving medical care through research and product development. The company supports standard of care guidelines and best practices in organ procurement to meet the needs of patients and physicians.

Recent Headlines

13 May 2008 European initiative kickoff in Germany
01 May 2008 Study shows Asporto limits degredation of the donor heart.
03 Mar 2008 “Hibernicor” is a registered service mark
28 Sep 2007 FDA and Hibernicor to have a pre-IDE meeting
31 Aug 2007 Praestro software installed at the University of Minnesota
26 Apr 2007 Asporto featured at the 27th Annual Meeting of the International Society for Heart and Lung Transplantation
12 Dec 2006 Winner - University of St. Thomas business plan competition